Screening NPS in urine
| Algemene gegevens | ||
| Therapeutische groep | drugs of abuse | |
| Synoniem | NPS; ‘designer drugs’; badzouten; ‘legal highs’; ‘research chemicals’ | |
| CTG-code | 72905 | |
| Bepalingsmethode | LC-HR-MS (screening) | |
| Bepalingsfrequentie | wekelijks | |
| Bepalingsdag(en) | afhankelijk van het aanbod | |
| Doorlooptijd (dagen) | 1 dag na analyse | |
| Spoed-bepaling | alleen na overleg met dienstdoende ziekenhuisapotheker (055-8446004 of buiten kantooruren via de centrale). | |
| Uitvoering | intern | |
| Accreditatie | ISO15189:2012 – M305 | |
| IVDR compliance | Laboratory Developed Test | Risicoklasse: C | Classificatie: IVb (raadpleeg het gedeelte ‘Kwaliteit’ voor de verklaring) | |
| Afname gegevens | ||
| Afnamemateriaal |  |  |
| Afnamematrix | urine | |
| Afnamevolume (mL) | minimaal 2 mL | |
| Afname tijdstip (@ steady state) | niet van toepassing | |
| Afnamecondities | chain of custody | |
| Verzend- en bewaarcondities | ||
| Bewaarconditie (°C) | 2 – 8°C (koelkast) | |
| Bewaartermijn (dagen) | 7 dagen | |
| Verzendconditie (°C) | 15 – 25°C (kamertemperatuur) | |
| Verzendadres | Gelre ziekenhuizen Klinisch Farmaceutisch en Toxicologisch Laboratorium (KFTL) Albert Schweitzerlaan 31 7334 DZ Apeldoorn. | |
| Monsterontvangst | centrale balie klinische chemie Gelre ziekenhuizen ziekenhuisapotheek-laboratorium Gelre ziekenhuizen | |
| Rapportagegegevens | ||
| Referentiewaarde | Afkapwaarde (ng/mL) | – |
| op basis NPS cut-off mengsel | 100 | – |
| Opmerking | Screening omvat meer dan 200 middelen, w.o. 3-MeO-PCP, 4-FA, cathinone, deschloroketamine, mefedron, methylon, mitragynine, etc. Zie overzicht NPS voor de middelen die onderdeel van de screening zijn. NB1. Geneesmiddelen zoals baclofen, modafinil en quetiapine worden ook gerapporteerd, omdat deze geneesmiddelen ook als drugs of abuse gebruikt kunnen worden. NB2. De methode wordt geregeld aangevuld met nieuwe middelen. Neem contact op met het apotheek laboratorium voor meer informatie indien het betreffende middel niet vermeld staat. Tevens is het mogelijk om een algemene toxicologische screening aan te vragen op basis van een bibliotheek met > 2.000 (genees)middelen. | |
| Achtergrondinformatie | ||
| Storende factoren | niet van toepassing | |
| Indicatie | de screening kan ingezet worden in het kader van: – een intoxicatie – bij een vermoeden van misbruik – tijdens detoxificatie NB1. Het blijft onduidelijk of er sprake is van eenmalig, sporadisch of frequent gebruik. NB2. Concentraties in urine zijn nauwelijks te relateren aan de concentratie in bloed, de ingenomen dosis of toxische effecten. | |
| Overige diagnostiek | kreatinine | |
| Farmacogenetica | niet van toepassing | |
| Referenties | – | |
| © 2020. Gelre-iLab, Gelre ziekenhuizen |
De screening omvat o.m. de volgende nieuwe psychoactieve stoffen
| Groep | Component | Afkorting | Straatnaam | Effect |
|---|---|---|---|---|
| Designer opioïden | ()-cis-Methyl butyryl fentanyl | – | – | Downer |
| Lysergamide | 1-Acetyl LSD | ALD-52 | – | Tripper |
| Piperazinen | 1-Benzylpiperazine | BZP | The Good Stuff, Smileys, Silver Bullet, etc. | Upper |
| Designer opioïden | 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine | MT-45; IC-6 | – | Downer |
| Designer opioïden | 2-Fluorofentanyl | o-FF | – | Downer |
| Phenethylaminen | 2,4,5-Trimethoxyamfetamine | TMA-2 | – | Tripper |
| Phenethylaminen | 2,5-Dimethoxy-4-Bromoamfetamine | DOB | – | Upper |
| Phenethylaminen | 2,5-Dimethoxy-4-Ethylthiophenethylamine | 2C-T-2 | – | Upper |
| Phenethylaminen | 2,5-Dimethoxyamfetamine | 2,5-DMA | – | Upper |
| Designer opioïden | 3-Fluoroisobutyrylfentanyl | m-FiBF | – | Downer |
| Designer opioïden | 3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide | U-48800 | – | Downer |
| Designer opioïden | 3,4-Dichloro-N-(2-dimethylamino)cyclohexyl)-N-methylbenzamide | U-47700 | U4, pink heroin, pinky, pink | Downer |
| Cathinonen | 3,4-Methylenedioxyamphetamine | MDA | – | Upper |
| Cathinonen | 3,4-Methylenedioxymethamphetamine | MDMA | Ecstasy | Upper |
| Phenethylaminen | 3,4,5-Trimethoxyamfetamine | TMA | – | Upper |
| Phenethylaminen | 4-Bromo-2,5-Dimethoxyphenethylamine | 2-CB | Venus; Nexus | Tripper |
| Designer opioïden | 4-Bromo-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]benzamide | U-47931E | Bromadolien | Downer |
| Cathinonen | 4-Chloromethcathinone | 4-CMC | Clephedrone | Upper |
| Phenethylaminen | 4-Fluoroamfetamine | 4-FA | Flux; 4-FMP | Upper |
| Phenethylaminen | 4-Methylamfetamine | – | – | Upper |
| Cathinonen | 4-Methylethcathinon | 4-MEC | – | Upper |
| Designer opioïden | 4-Methylfentanyl | 4-MF | – | Downer |
| Designer opioïden | 4-Methylfuranylfentanyl | – | – | Downer |
| Cathinonen | 4-Methylmethcathinon | 4-MMC | Meow Meow; Miauw Miauw; Mcat; Mefedron | Upper |
| Designer opioïden | Acryloylfentanil; acrylfentanyl | – | – | Downer |
| Designer opioïden | Alfentanil | – | – | Downer |
| Designer opioïden | Alpha-Methylacetylfentanyl | – | – | Downer |
| Designer opioïden | Alpha-Methylbutyrylfentanyl | – | – | Downer |
| Designer opioïden | Alpha-Methylfentanyl | – | – | Downer |
| Designer opioïden | Alpha-Methylthiofentanyl | – | – | Downer |
| Tryptaminen | Alpha-Methyltryptamine | AMT | – | Tripper |
| Phenethylaminen | Amfepramone | – | – | Upper |
| Overig | Aminorex | – | – | Upper |
| Phenethylaminen | Benzfetamine | – | – | Upper |
| Cathinonen | Benzoylethanamine | Cathinon | Khat | Upper |
| Designer opioïden | Benzylcarfentanil | – | – | Downer |
| Phenethylaminen | Benzylfentanyl | R4129 | – | Downer |
| Designer opioïden | Beta-Hydroxyfentanyl | – | – | Downer |
| Designer opioïden | Beta-Hydroxythiofentanyl | – | – | Downer |
| Designer opioïden | Beta-methylfentanyl | – | – | Downer |
| Tryptaminen | Bufotenine | 5-HO-DMT | – | Tripper |
| Designer opioïden | Butorphanol | – | – | Downer |
| Overig | Butylscopolamine | – | – | Downer |
| Designer opioïden | Butyrfentanyl | – | – | Downer |
| Designer opioïden | Carfentanil | – | – | Downer |
| Overig | Cathine (Norpseudoephedrine; phenylpropanolamine) | – | – | Upper |
| Cathinonen | Cathinone | – | – | Upper |
| Overig | Convallatoxin | – | – | Downer |
| Designer opioïden | Crotonylfentanyl | – | – | Downer |
| Designer opioïden | Cyclobutylfentanyl | – | – | Downer |
| Designer opioïden | Cyclohexylfentanyl | – | – | Downer |
| Designer opioïden | Cyclopentylfentanyl | – | – | Downer |
| Designer opioïden | Cyclopropylfentanyl | – | – | Downer |
| Designer opioïden | Desomorphine | – | – | Downer |
| Designer opioïden | Despropionyl para-fluorofentanyl | – | – | Downer |
| Overig | Dihydroergotamine | – | – | Downer |
| Designer opioïden | Dihydromorphine | – | – | Downer |
| Tryptaminen | Dimethyltryptamine | DMT | – | Tripper |
| Overig | Ephedrine | – | – | Upper |
| Overig | Ephedrine/pseudoephedrine | – | – | Upper |
| Overig | Ergotamine | – | – | Downer |
| Designer opioïden | Ethylmorphine | – | – | Downer |
| Overig | Fenfluramine/Dexfenfluramine | – | – | Upper |
| Overig | Fenproporex | – | – | Upper |
| Designer opioïden | Fentanyl | – | – | Downer |
| Designer opioïden | Fentanyl, Nor | – | – | Downer |
| Designer opioïden | Furanylethylfentanyl | – | – | Downer |
| Designer opioïden | Furanylfentanyl | – | – | Downer |
| Overig | Ibogaine | – | – | Tripper |
| Designer opioïden | Isobutyrylfentanyl (iBF) | iBF | – | Downer |
| Overig | Ketobemidon | – | – | Downer |
| Designer opioïden | Levorphanol/dextrophan | – | – | Downer |
| Lysergamide | LSD-M (2-Oxo-hydroxy metabolite) | – | – | Tripper |
| Lysergamide | Lysergic acid diethylamide | LSD | Acid | Tripper |
| Overig | Mazindol | – | – | Upper |
| Designer opioïden | Meperidine | – | – | Downer |
| Overig | Mephentermine | – | – | Upper |
| Phenethylaminen | Mescaline | – | – | Tripper |
| Cathinonen | Metaphedrone; 3-Methylmethcathinon | 3-MMC | Poes | Upper |
| Cathinonen | Methamfetamine | – | – | Upper |
| Cathinonen | Methcathinone (Ephedrone) | – | – | Upper |
| Arylcyclohexylaminen | Methoxphenidine (methoxydiphenidine) | MXP | – | Tripper |
| Designer opioïden | Methoxyacetylfentanyl | – | – | Downer |
| Overig | Methoxymethamfetamine | PMMA | – | Upper |
| Phenethylaminen | Methylon; 3,4-Methylenedioxymethcathinone | – | Explosion; bk-MDMA; Ease; M | Upper |
| Cathinonen | Methylone-M (demethylation) | – | – | Upper |
| Cathinonen | Methylone-M (hydroxylation) | – | – | Upper |
| Cathinonen | N-Ethyl-1-(3,4-methylenedioxyphenyl)-2-ethanamine | MDEA | – | Upper |
| Designer opioïden | N-Methylcarfentanil | – | – | Downer |
| Designer opioïden | N,N-Didesmethyl U-47700 | – | – | Downer |
| Designer opioïden | Nalbuphine | – | – | Downer |
| Designer opioïden | Nicomorphine | – | – | Downer |
| Overig | Nicotine | – | – | Upper |
| Overig | Norefedrine | – | – | Upper |
| Designer opioïden | Normeperidine | – | – | Downer |
| Designer opioïden | Ocfentanil | – | – | Downer |
| Overig | Pemoline | – | – | Upper |
| Arylcyclohexylaminen | Phencyclidine | PCP | Angel Dust | Tripper |
| Overig | Phendimetrazine | – | – | Upper |
| Overig | Phenmetrazine | – | – | Upper |
| Overig | Phentermine | – | – | Upper |
| Designer opioïden | Phenylacetylfentanyl | – | – | Downer |
| Designer opioïden | Phenylfentanyl | – | – | Downer |
| Designer opioïden | Pholcodine | – | – | Downer |
| Tryptaminen | Psilocin | – | – | Tripper |
| Tryptaminen | Psilocybin | – | – | Tripper |
| Cathinonen | Pyrovalerone | – | – | Upper |
| Designer opioïden | Tapentadol | – | – | Downer |
| Designer opioïden | Tetrahydrofuran Fentanyl (THF fentanyl) | – | – | Downer |
| Designer opioïden | Tetrahydrofuranfentanyl 3-tetrahydrofurancarboxamide (3-THF fentanyl) | – | – | Downer |
| Overig | Thebacon | – | – | Downer |
| Overig | Thebaine | – | – | Downer |
| Designer opioïden | Thienylfentanyl | – | – | Downer |
| Designer opioïden | Thiofentanyl | – | – | Downer |
| Designer opioïden | Thiofuranylfentanyl | – | – | Downer |
| Designer opioïden | Tilidine | – | – | Downer |
| Designer opioïden | Tilidine, Nor | – | – | Downer |
| Designer opioïden | trans-(+)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide | U-50488 | – | Downer |
| Overig | Trazodone | – | – | Downer |
| Designer opioïden | Valerylfentanyl | – | – | Downer |
| Designer benzodiazepinen | Zolazepam | – | – | Downer |
| Overig | 4-Anilino-N-phenethylpiperidine | 4-ANPP | Despropionylfentanyl | Precursor |
| Designer opioïden | (1R,2R)-3-(3,4-Dichlorophenyl)-N,N-dimethyl-N-[(1S,2S)-2-(dimethylamino)cyclohexyl]propanamide | U-51754 | – | Downer |
| Designer opioïden | (5Alpha,7alpha,8beta)-(+)-N-Methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]decan-8-yl]-benzeneacetamide | U-69,593 | – | Downer |
| Piperazinen | 1-(2-Chlorophenyl)piperazine | oCPP | – | Upper |
| Piperazinen | 1-(2-Methoxyphenyl)piperazine | oMeOPP | – | Upper |
| Piperazinen | 1-(3-Chlorophenyl)piperazine; meta-Chloor-Phenyl-Piperazine | mCPP | The Good Stuff, Smileys, Silver Bullet, etc. | Upper |
| Piperazinen | 1-(3-Methylphenyl)piperazine | mMPP | – | Upper |
| Piperazinen | 1-(4-Methoxyphenyl)piperazine | pMeOPP | – | Upper |
| Piperazinen | 1-(4-Methylphenyl)piperazine | pMPP | The Good Stuff, Smileys, Silver Bullet, etc. | Upper |
| Piperazinen | 1-(p-Fluorophenyl)piperazine | pFPP | – | Upper |
| Piperazinen | 1-Methyl-4-Benzylpiperazine | MBZP | – | Upper |
| Cathinonen | 1-Naphyrone | O-2482 | – | Upper |
| Lysergamide | 1-Propionyl-d-lysergic acid diethylamide | 1P-LSD | – | Tripper |
| Piperazinen | 1,4-Dibenzypiperazine | DBZP | – | Upper |
| Phenethylaminen | 2-(2,5-Dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | 2C-H-NBOMe; 25H-NBOMe | – | Tripper |
| Phenethylaminen | 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | 2C-B-NBOMe; 25B-NBOMe | NBOMe-2C-B, Cimbi-36, Nova, BOM 2-CB | Tripper |
| Phenethylaminen | 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | 2C-C-NBOMe; 25C-NBOMe | – | Tripper |
| Phenethylaminen | 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | 2C-I-NBOMe; 25I-NBOMe | – | Tripper |
| Cathinonen | 2-Ethylamino-1-(3,4-Methylenedioxyphenyl)propan-1-one | bkMDEA | – | Upper |
| Designer opioïden | 2-Fluoroacrylfentanyl | – | – | Downer |
| Phenethylaminen | 2-Fluoroamfetamine | 2-FA | – | Upper |
| Designer opioïden | 2-Fluorobutyrylfentanyl | o-FBF | – | Downer |
| Designer opioïden | 2-Fluoroisobutyrylfentanyl | o-FiBF | – | Downer |
| Phenethylaminen | 2-Fluoromethcathinone | 2-FMC | – | Upper |
| Cathinonen | 2-Methylamino-1-(3,4-Methylenedioxyphenyl)butan-1-one | bkMBDB | – | Upper |
| Cathinonen | 2-Methylamino-1-(3,4-Methylenedioxyphenyl)propan-1-one | bkMDMA | – | Upper |
| Designer opioïden | 2-Methylbutyrylfentanyl | o-MBF | – | Downer |
| Designer opioïden | 2-Methylfentanyl | o-MF | – | Downer |
| Designer opioïden | 2-Methylfuranylfentanyl | o-MFF | – | Downer |
| Cathinonen | 2-Methylmethcathinone | 2-MMC | – | Upper |
| Phenethylaminen | 2,4,6-Trimethoxyamfetamine | TMA-6 | – | Tripper |
| Phenethylaminen | 2,5-Dimethoxy-4-Bromoamphetamine Fly | 2C-B-Fly | – | Tripper |
| Phenethylaminen | 2,5-Dimethoxy-4-Chloroamfetamine | DOC | – | Upper |
| Phenethylaminen | 2,5-Dimethoxy-4-Chlorophenethylamine | 2C-C | – | Tripper |
| Phenethylaminen | 2,5-Dimethoxy-4-Ethylphenethylamine | 2C-E | – | Tripper |
| Phenethylaminen | 2,5-Dimethoxy-4-Iodoamfetamine | DOI | – | Upper |
| Phenethylaminen | 2,5-Dimethoxy-4-Iodophenethylamine | 2CI | – | Upper |
| Phenethylaminen | 2,5-Dimethoxy-4-Methylamfetamine | STP | – | Upper |
| Phenethylaminen | 2,5-Dimethoxy-4-Methylphenethylamine | 2C-D | – | Upper |
| Phenethylaminen | 2,5-Dimethoxy-4-Methylthiophenethylamine | 2C-T | – | Tripper |
| Phenethylaminen | 2,5-Dimethoxy-4-Nitrophenethylamine | 2C-N | – | Tripper |
| Phenethylaminen | 2,5-Dimethoxy-4-Propylphenethylamine | 2C-P | – | Tripper |
| Phenethylaminen | 2,5-Dimethoxyphenethylamine | 2-CH | – | Upper |
| Phenethylaminen | 2,5-Dimethyoxy-4-(i)-propylthiophenethylamine | 2C-T-4 | – | Upper |
| Phenethylaminen | 3-Fluoroamfetamine | 3-FA | – | Upper |
| Designer opioïden | 3-Fluorobutyrylfentanyl | m-FBF | – | Downer |
| Designer opioïden | 3-Fluorofentanyl | m-FF | – | Downer |
| Cathinonen | 3-Fluoroisomethcathinone | iso 3-FMC | – | Upper |
| Phenethylaminen | 3-Fluoromethamfetamine | 3-FMA | – | Upper |
| Cathinonen | 3-Fluoromethcathinone | 3-FMC | – | Upper |
| Designer opioïden | 3-Fluoromethoxyacetylfentanyl | – | – | Downer |
| Overig | 3-Fluorophenmetrazine | 3-FPM | 3-FPH; PAL-593 | Upper |
| Arylcyclohexylaminen | 3-Methoxyeticyclidine | 3-MeO-PCE | – | Tripper |
| Arylcyclohexylaminen | 3-Methoxyphencyclidine | 3-MeO-PCP | – | Tripper |
| Phenethylaminen | 3-Methylbuphedrone | – | – | Upper |
| Designer opioïden | 3-Methylfentanyl (cis) | – | – | Downer |
| Designer opioïden | 3-Methylfentanyl (trans) | – | – | Downer |
| Designer opioïden | 3-Methylfuranylfentanyl | – | – | Downer |
| Designer opioïden | 3-Methylmethoxyacetylfentanyl | – | – | Downer |
| Cathinonen | 3,4 Dimethylmethcathinone | 3,4-DMMC | – | Upper |
| Overig | 3,4-Dichloromethylphenidate | 3,4 CTMP | – | Upper |
| Cathinonen | 3,4-Methylenedioxy-a-pyrrolidinobutyrophenone | MDPBP | – | Upper |
| Cathinonen | 3,4-Methylenedioxy-N-benzylcathinone | BMDP | – | Upper |
| Phenethylaminen | 3,4-Methylenedioxybutanphenamine | BDB | – | Upper |
| Cathinonen | 3′,4′-Methylenedioxy-alpha-pyrrolidinohexiophenone | MDPHP | – | Upper |
| Cathinonen | 3′,4′-Methylenedioxy-alpha-pyrrolidinopropiophenone | MDPPP | – | Upper |
| Cathinonen | 3′,4′-Methylenedioxypyrovalerone | MDPV | – | Upper |
| Tryptaminen | 4-Acetoxy-N-methyl-N-ethyltryptamine | 4-AcO-MET | – | Tripper |
| Tryptaminen | 4-Acetoxy-N,N-diisopropyltryptamine | 4-Acetoxy-DiPT | Ipracetin | Tripper |
| Phenethylaminen | 4-Bromoamfetamine | PBA | – | Upper |
| Phenethylaminen | 4-Chlooramfetamine | – | – | Upper |
| Designer opioïden | 4-Chlorofentanyl (p-Chlorofentanyl) | – | – | Downer |
| Designer opioïden | 4-Chloroisobutyrfentanyl | p-Cl-iBF | – | Downer |
| Cathinonen | 4-Ethylethcathinone | 4-EEC | – | Upper |
| Cathinonen | 4-Ethylmethcathinone | p-EMC | – | Upper |
| Designer opioïden | 4-Fluoroacrylfentanyl | – | Downer | |
| Designer opioïden | 4-Fluorobutyrylfentanyl | p-FBF | – | Downer |
| Overig | 4-Fluorococaine | – | – | Upper |
| Designer opioïden | 4-Fluorocyclopropylfentanyl | – | Downer | |
| Overig | 4-Fluoroethylfenidate | 4F-EPH | – | Upper |
| Designer opioïden | 4-Fluorofentanyl | p-FF | Downer | |
| Designer opioïden | 4-Fluorofuranylfentanyl | – | Downer | |
| Designer opioïden | 4-Fluorofuranylfentanyl 3-furancarboxamide | – | Downer | |
| Designer opioïden | 4-Fluoroisobutyrylfentanyl | p-FiBF | – | Downer |
| Phenethylaminen | 4-Fluoromethamfetamine | 4-FMA | – | Upper |
| Cathinonen | 4-Fluoromethcathinone | 4-FMC | Upper | |
| Designer opioïden | 4-Fluoromethoxyacetyl fentanyl | – | Downer | |
| Overig | 4-Fluoromethylphenidate | 4-FMPH; 4F-MPH | Upper | |
| Designer opioïden | 4-Fluorotetrahydrofuran fentanyl | – | Downer | |
| Overig | 4-Fluorotropacocaine | pFBT | – | Upper |
| Phenethylaminen | 4-Hydroxy-3-methoxymethamfetamine | HMMA | actieve metaboliet van MDMA | Upper |
| Tryptaminen | 4-Hydroxy-MET | 4-HO-MET | colour, methylcybin, metocin | Tripper |
| Phenethylaminen | 4-Methoxyamfetamine | PMA; 4-MA | – | Upper |
| Designer opioïden | 4-Methoxybutyrylfentanyl | 4-MeO-BF | – | Downer |
| Arylcyclohexylaminen | 4-Methoxyphencyclidine | 4-MeO-PCP | – | Tripper |
| Cathinonen | 4-Methyethcathinone | 4-MEC, NRG-2 | – | Upper |
| Cathinonen | 4-Methyl-a-pyrrolidinobutio-phenone | 4-MePBP | Onbekend | Upper |
| Cathinonen | 4-Methyl-N-benzylcathinone | Benzedrone | – | Upper |
| Cathinonen | 4-Methyl-N-Methylbuphedrone | 4-ME-MB | Onbekend | Upper |
| Designer opioïden | 4-Methylacetylfentanyl | – | – | Downer |
| Designer opioïden | 4-Methylbutyrylfentanyl | – | – | Downer |
| Cathinonen | 4-Methylhexedrone | – | – | Upper |
| Phenethylaminen | 4-Methylmethamfetamine | 4-MMA | – | Upper |
| Designer opioïden | 4-Methylmethoxyacetylfentanyl | – | – | Downer |
| Overig | 4-Methylmethphenidate | 4-MeTMP | – | Upper |
| Designer opioïden | 4-Methyltetrahydrofuranfentanyl | – | – | Downer |
| Phenethylaminen | 4-MethylThioamfetamine | 4-MTA | – | Upper |
| Designer opioïden | 4-Methyoxyfentanyl | – | – | Downer |
| Overig | 4,4-Dimethylaminorex | 4,4-DMAR | – | Upper |
| Piperidinen and pyrrolidinen | 4′-Methyl-α-pyrrolidinopropiophenone | 4-MePPP; MPPP | – | Upper |
| Phenethylaminen | 5-(2-Aminopropyl)benzofuran | 5-APB | – | Upper |
| Tryptaminen | 5-(2-Aminopropyl)indole | 5-API; 5-IT | – | Upper |
| Phenethylaminen | 5-(2-Ethylaminopropyl)benzofuran | 5-EAPB | – | Upper |
| Phenethylaminen | 5-(2-Methylaminopropyl)benzofuran | 5-MAPB | – | Upper |
| Phenethylaminen | 5-APDB / 6-APDB (3-Desoxy-MDA / 4-Desoxy-MDA) | 5-APDB/6-APDB | – | Upper |
| Aminoindanen | 5-Iodo-2-aminoindane | 5-IAI | – | Upper |
| Tryptaminen | 5-MeO-DMT (N,N-Dimethyl-5-methoxytryptamine) | 5-MeO-DMT | Tripper | |
| Tryptaminen | 5-Methoxy-alpha-methyltryptamine | 5-MeO-AMT | – | Tripper |
| Tryptaminen | 5-Methoxy-N-Methyl-N-isopropyltryptamine | 5-MeO-MiPT | Tripper | |
| Tryptaminen | 5-Methoxy-N,N-diallyltryptamine | 5-MeO-DALT | – | Tripper |
| Tryptaminen | 5-Methoxy-N,N-diisopropyltryptamine | 5-MeO-DiPT | – | Tripper |
| Aminoindanen | 5,6-Methylenedioxy-2-aminoindane | MDAI | MDAI gold | Upper |
| Phenethylaminen | 6-(2-Aminopropyl)benzofuran | 6-APB | Benzo Fury | Upper |
| Lysergamide | 6-allyl-6-nor-LSD | AL-LAD | – | Tripper |
| Lysergamide | 6-Ethyl-6-nor-lysergic acid diethylamide | ETH-LAD | – | Tripper |
| Designer opioïden | Acetylfentanyl | – | – | Downer |
| Designer opioïden | Acetylnorfentanyl | – | – | Downer |
| Designer opioïden | AH-7921 | – | – | Downer |
| Phenethylaminen | Allylescaline | – | – | Tripper |
| Cathinonen | Alpha PVP-M (2″-oxo-PVP metabolite) | – | – | Upper |
| Cathinonen | Alpha PVP-M (5-HO-PVP metabolite) | – | – | Upper |
| Cathinonen | Alpha-Pyrrolidinobutiophenone | Alpha-PBP | – | Upper |
| Cathinonen | Alpha-Pyrrolidinohexiophenone | Alpha-PHiP | – | Upper |
| Cathinonen | Alpha-Pyrrolidinopentiothiophenone | Alpha-PVT | – | Upper |
| Cathinonen | Alpha-Pyrrolidinopropiophenone | Alpha-PPP | – | Upper |
| Aminoindanen | Aminoindane (2-AI) | 2-AI | – | Upper |
| Designer benzodiazepinen | Bentazepam | – | – | Downer |
| Designer opioïden | Benzodioxolefentanyl | – | – | Downer |
| Overig | Beta-Fenyl-gamma-aminoboterzuur | Fenibut | – | Downer |
| Phenethylaminen | Beta-Keto-2C-B | – | – | Tripper |
| Phenethylaminen | Bromobenzodifuranylisopropylamine | – | Bromodragon Fly; 3C-Bromo-Dragonfly; DOB-Dragonfly | Tripper |
| Cathinonen | Buphedrone (alpha methylamino-butyrophenone) | MABP | – | Upper |
| Cathinonen | Buphedrone-M (ephedrine metabolite) | – | – | Upper |
| Phenethylaminen | Camfetamine | – | – | Upper |
| Phenethylaminen | Clobenzorex | – | – | Upper |
| Overig | Clomethiazole | – | – | Downer |
| Designer benzodiazepinen | Cloxazolam | – | – | Downer |
| Overig | Cyclohexylamine | – | – | Downer |
| Designer benzodiazepinen | Deschloroetizolam | – | – | Downer |
| Arylcyclohexylaminen | Deschloroketamine | DXE; 2′-Oxo-PCM | – | Tripper |
| Overig | Desoxypipradol | 2-DPMP | – | Upper |
| Overig | Dextromethorphan | – | – | Tripper |
| Cathinonen | Dibutylone | bkMMBDB | – | Upper |
| Designer benzodiazepinen | Diclazepam | – | – | Downer |
| Tryptaminen | Diethyltryptamine | – | – | Tripper |
| Overig | Dimethocaine | – | – | Upper |
| Cathinonen | Dimethylcathinone | DMC | – | Upper |
| Cathinonen | Dimethylone | bk-MDDMA | – | Upper |
| Cathinonen | Dimethylone-M (demethylenated) | – | – | Upper |
| Cathinonen | Dimethylone-M (hydroxyated) | – | – | Upper |
| Cathinonen | Dimethylone-M (methylated) | – | – | Upper |
| Arylcyclohexylaminen | Diphenidine | – | – | Tripper |
| Overig | Diphenylprolinol | D2PM | – | Upper |
| Tryptaminen | Dipropyltryptamine | DPT | – | Tripper |
| Overig | Ephedrine-M (Nor N-diethyl) | – | – | Upper |
| Phenethylaminen | Escaline (4-Ethoxymescaline) | – | – | Tripper |
| Cathinonen | Ethcathinone (EC) | EC | – | Upper |
| Cathinonen | Ethylone | – | – | Upper |
| Overig | Ethylphenidate | – | – | Upper |
| Designer benzodiazepinen | Etizolam | – | – | Downer |
| Cathinonen | Eutylone | – | – | Upper |
| Overig | Fencamfamine | – | – | Upper |
| Overig | Fenozolone | – | – | Upper |
| Overig | Fipexide | – | – | Upper |
| Designer benzodiazepinen | Flubromazepam | – | – | Downer |
| Designer benzodiazepinen | Flubromazolam | – | – | Downer |
| Cathinonen | Hexedrone | – | – | Upper |
| Overig | HMMA | – | Actieve metaboliet van MDMA | Upper |
| Overig | Homatropine | – | – | Downer |
| Overig | Hordenine | – | – | Upper |
| Overig | Hyocyamine | – | – | Downer |
| Overig | Ligandrol 2226 | LGD-2226 | – | Upper |
| Piperazinen | m-Trifluorophenylpiperazine | TFMPP | The Good Stuff, Smileys, Silver Bullet, etc. | Upper |
| Cathinonen | Mephedrone, demethyl metabolite | – | – | Upper |
| Cathinonen | Mephedrone, hydroxy metabolite | – | – | Upper |
| Cathinonen | Methedrone | bk-PMMA | – | Upper |
| Cathinonen | Methiopropamine | MPA | – | Upper |
| Arylcyclohexylaminen | Methoxetamine | MXE | Mexxy; Mexy; MKET; Moxy; Rhino Ket; Roflcoptr | Tripper |
| Overig | Methylephedrine | – | – | Upper |
| Overig | Methylergonovine | – | – | Downer |
| Designer benzodiazepinen | Metizolam | – | – | Downer |
| Cathinonen | Mexedrone | – | – | Upper |
| Planten and extracten | Mitragynine | – | Kratom; Herbal Speedball; Biak-biak | Downer |
| Planten and extracten | Mitragynine-M (7 hydroxy) | – | – | Downer |
| Cathinonen | MPBP (4′-Methyl-a-pyrrolidinobutiophenone) | MPBP | – | Upper |
| Cathinonen | MPHP (4′-Methyl-a-pyrrolidinohexiophenone) | MPHP | – | Upper |
| Cathinonen | N-benzyl-(3,4-methylene-dioxyphenyl)-2-aminobutan-1-one (N-benzyl-norbutylone) | – | – | Upper |
| Cathinonen | N-Ethylbuphedrone (NEB) | – | – | Upper |
| Cathinonen | N-Ethylhexedrone | – | – | Upper |
| Cathinonen | N-Ethylpentylone | – | – | Upper |
| Cathinonen | N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine | MBDB | – | Upper |
| Designer opioïden | N-Phenyl-N-(piperidin-4-yl)butyramide | U-49900 | – | Downer |
| Tryptaminen | N,N-di allyl-5-methoxy tryptamine | 5-MeO-DALT | – | Tripper |
| Tryptaminen | N,N-Diisopropyltryptamine | DiPT | – | Tripper |
| Overig | Niaprazine | – | – | Downer |
| Designer benzodiazepinen | Nifoxipam | – | – | Downer |
| Overig | Nitracaine | – | – | Upper |
| Aminoindanen | NM-2AI (N-Methyl-2-Aminoindane) | NM-2AI | – | Upper |
| Overig | Norfenfluramine | – | – | Upper |
| Tryptaminen | O-Acetylpsilocin; 4-acetoxy-DMT | 4-AcO-DMT | – | Tripper |
| Cathinonen | Pentedrone | – | – | Upper |
| Cathinonen | Pentylone | bkMBDP | – | Upper |
| Overig | Phenethylamine | PEA | – | Upper |
| Overig | Phenibut | – | – | Downer |
| Overig | Pheniramine | – | – | Downer |
| Overig | Pholedrine (4-hydroxymethamfetamine) | – | – | Upper |
| Overig | Prenylamine | – | – | Downer |
| Overig | Prolintane | – | – | Upper |
| Designer benzodiazepinen | Pyrazolam | – | – | Downer |
| Overig | Tropacocaine | – | – | Upper |
| Tryptaminen | Tryptamine | – | – | Tripper |
| Overig | Yohimbine | – | – | Upper |
| Designer benzodiazepinen | Zolazepam | – | – | Downer |
Deze lijst is informatief en er kunnen geen rechten aan worden ontleend. Eventuele onjuistheden kunt u melden via ons contactformulier.